Uh-oh! This study is no longer available.
We're sorry, but the study or condition you’re looking for is no longer available. You can search all currently enrolling studies or contact us if you have any questions.
Invasive Urothelial Carcinoma – Post-Surgery Treatment
Medical Condition
Cancer
Facility/Clinic
PMG Research of DuPage Medical Group
Age
18 or older
Gender
Male/Female
Description
A research study is evaluating whether an investigational medication may lower the chances of the bladder cancer to return in patients who have had surgery to remove invasive urothelial carcinoma.
This research study may be an option if you:
• Have a diagnosis of invasive urothelial carcinoma
• Have FGFR3 Alterations
• Had nephroureterectomy, distal ureterectomy, or cystectomy within 120 days
Additional inclusion and exclusion criteria apply. Patients must meet all eligibility criteria to be considered for the clinical research study.
Qualified participants will receive study medication or placebo at no cost. You will not be required to pay for any study related procedures. You or your insurance company may be billed for any other health care costs, including those standard of care procedures that you receive while participating in the study.
Enrollment
Open
Patient Commitment Duration
Dependent on disease status (such as recurrence
Patient Compensation
Financial compensation may be provided for travel expenses.
Number of visits in study
Dependent on the length of participation in the study
117 1303 1
